Liver International

Papers
(The H4-Index of Liver International is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)
ArticleCitations
Frequency of the PNPLA3 rs738409 polymorphism and other genetic loci for liver disease in a Guatemalan adult population208
Navigating portal hypertension: Unlocking safe passage to healthy pregnancy in EHPVO186
Long‐term outcomes after liver transplantation for ACLF – Don’t forget quality of life!157
Author's reply: The relationship between systemic inflammation and liver fibrogenesis in patients with cirrhosis93
Different methodologies of protein induced by vitamin K absence or antagonist II in patients without hepatocellular carcinoma92
Letter to the Editor regarding “Long‐term exposure to air pollution and incident non‐alcoholic fatty liver disease and cirrhosis”91
MNS1 promotes hepatocarcinogenesis and metastasis via activating PI3K/AKT by translocating β‐catenin and predicts poor prognosis89
No impact of COVID‐19 epidemic on decompensation of alcoholic liver disease: Results from a single centre in Milan81
DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN‐0179
Clinical, neuropsychological and neurophysiological indices and predictors of hepatic encephalopathy (HE)75
High disease burden and healthcare resource usage in patients with acute porphyria—A population‐based analysis63
Intraindividual comparison of prognostic imaging features of HCCs between MRIs with extracellular and hepatobiliary contrast agents62
AI‐based digital pathology provides newer insights into lifestyle intervention‐induced fibrosis regression in MASLD: An exploratory study62
Cover Image61
High end‐of‐treatment hepatitis B core‐related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy61
Issue Information59
Reply to: “Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank”59
54
Effect of statins on the recurrence of hepatocellular carcinoma after liver transplantation: An illusion revealed by exposure density sampling53
Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank53
Prevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction‐associated fatty liver disease in Korea51
51
50
Tolvaptan for difficult‐ to ‐treat ascites: Difficulties in opening doors for GWAS application49
Issue Information46
Is fresh frozen plasma transfusion associated with outcomes in acute variceal bleeding?45
Issue Information45
Improving the accuracy of outcome prediction for hepatocellular carcinoma: Asia strategies44
MR elastography to predict haemodynamic response to beta‐blockers—The story is still incomplete43
How to get away with liver innate immunity? A viruses’ tale43
Unlocking liver health: Can tackling myosteatosis spark remission in metabolic dysfunction‐associated steatotic liver disease?42
Prognosis algorithms for acute decompensation of cirrhosis and ACLF41
Improving prediction of hepatocellular carcinoma in chronic hepatitis B by machine learning: Productive relationship of medicine with computer science41
Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology41
41
HBV cure—The light at the end of the tunnel?40
Hepatitis delta virus infection in the Middle East39
Issue Cover39
High prevalence of lower limb atherosclerosis is linked with the gut–liver axis in patients with primary biliary cholangitis38
0.13055992126465